EUVIMEDEUVIMED entdecken
Crossref

Association of Serum Thromboinflammatory Biomarkers With Atherosclerotic Plaques and Burden in a Community-Based Population

Baoshan Qiu iD, Xueli Cai iD, Lebo Zhou iD, Xuan Wang iD, Shan Li iD, Nan Wang iD, Lingling Jiang, Jing Jing iD, Tiemin Wei iD, Yongjun Wang iD, Yuesong Pan iD, Yilong Wang iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2025

DOI: 10.1161/atvbaha.125.322586 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025. Verfasst von Baoshan Qiu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Beijing Tiantan Hospital (B.Q., L.Z., X.W., N.W., L.J., J.J., Yongjun Wang, Y.P., Yilong Wang), Capital Medical University, …. Hauptthemen laut MEDLINE: Plaque, Atherosclerotic, Coronary Artery Disease, Inflammation Mediators, Intracranial Arteriosclerosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The pathogenesis of atherosclerosis involves complex mechanisms, with inflammation playing a central role. Thromboinflammation may contribute to its development and progression. We investigated the association between circulating thromboinflammatory biomarkers and atherosclerotic plaques. METHODS: Participants aged 50 to 75 years from the baseline survey of the PRECISE study (Polyvascular Evaluation for Cognitive Impairment and Vascular Events) were included. Serum levels of thromboinflammatory biomarkers (sGPVI [soluble glycoprotein VI]; sADAMTS13 [soluble a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13]; and sP-selectin) were assessed by ELISA and Luminex assays and categorized into quartiles based on their empirical distribution within the study population. Eligible participants underwent imaging using computed tomography angiography and magnetic resonance imaging for coronary atherosclerosis, intracranial atherosclerosis, and extracranial atherosclerosis, respectively. RESULTS: A total of 3019 participants (mean age, 61.20±6.68 years; 46.47% male) were analyzed. After multivariable adjustment, participants in the fourth quartile of sGPVI levels had higher odds of coronary atherosclerotic plaque burden (common odds ratio, 1.42 [95% CI, 1.14–1.76]; P =0.0017). Conversely, those in the highest sADAMTS13 quartile had lower odds of coronary plaques (odds ratio, 0.75 [95% CI, 0.60–0.93]; P =0.0094), as well as reduced coronary plaque burden, including segment involvement score (common odds ratio, 0.75 [95% CI, 0.61–0.93]; P =0.0087) and segment stenosis score (common odds ratio, 0.75 [95% CI, 0.61–0.93]; P =0.0086). No significant associations were observed between sGPVI or sADAMTS13 levels and intracranial or extracranial atherosclerosis. Likewise, after multivariable adjustment, no significant associations were observed between sP-selectin (soluble P-selectin) levels and coronary, intracranial, or extracranial atherosclerosis. CONCLUSIONS: In our study, serum sADAMTS13 levels showed a negative association with both the presence and burden of coronary atherosclerosis, while sGPVI levels showed a positive association with the burden of coronary atherosclerosis. However, significant associations between the level of thromboinflammatory biomarkers, intracranial atherosclerosis, and extracranial atherosclerosis were not found.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plaque, AtheroscleroticCoronary Artery DiseaseInflammation MediatorsIntracranial ArteriosclerosisInflammationHumansMaleFemaleBiomarkersMiddle AgedAgedComputed Tomography AngiographyRisk FactorsP-SelectinCross-Sectional StudiesPredictive Value of Tests

Stichwörter der Autor:innen

atherosclerosisischemic strokemyocardial infarctionplaque, atheroscleroticthrombosis

Substanzen

BiomarkersInflammation MediatorsP-SelectinSELP protein, human

Autor:innen und Institutionen

  • Department of Neurology, Beijing Tiantan Hospital (B.Q., L.Z., X.W., N.W., L.J., J.J., Yongjun Wang, Y.P., Yilong Wang), Capital Medical University, China.
  • Chinese Institute for Brain Research, Beijing (B.Q., L.Z., N.W., Yilong Wang).
  • China National Clinical Research Center for Neurological Diseases, Beijing (B.Q., X.W., L.J., J.J., Yongjun Wang, Yilong Wang).
  • Cerebrovascular Research Laboratory, Department of Neurology, and Department of Cardiology, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, China (X.C., S.L., T.W.).
  • Advanced Innovation Center for Human Brain Protection (Yongjun Wang, Yilong Wang), Capital Medical University, China.
  • Beijing Laboratory of Oral Health (Yilong Wang), Capital Medical University, China.

ORCID-Profile: Baoshan Qiu, Xueli Cai, Lebo Zhou, Xuan Wang, Shan Li, Nan Wang, Jing Jing, Tiemin Wei, Yongjun Wang, Yuesong Pan, Yilong Wang

Zitieren

APA

Qiu, B., Cai, X., Zhou, L., Wang, X., Li, S., Wang, N., Jiang, L., Jing, J., Wei, T., Wang, Y., Pan, Y., & Wang, Y. (2025). Association of Serum Thromboinflammatory Biomarkers With Atherosclerotic Plaques and Burden in a Community-Based Population. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.125.322586

Vancouver

Qiu B, Cai X, Zhou L, Wang X, Li S, Wang N, et al. Association of Serum Thromboinflammatory Biomarkers With Atherosclerotic Plaques and Burden in a Community-Based Population. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025. doi:10.1161/atvbaha.125.322586

BibTeX
@article{Qiu2025,
  author = {Qiu, Baoshan and Cai, Xueli and Zhou, Lebo and Wang, Xuan and Li, Shan and Wang, Nan and Jiang, Lingling and Jing, Jing and Wei, Tiemin and Wang, Yongjun and Pan, Yuesong and Wang, Yilong},
  title = {Association of Serum Thromboinflammatory Biomarkers With Atherosclerotic Plaques and Burden in a Community-Based Population},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2025},
  doi = {10.1161/atvbaha.125.322586}
}
Kostenlos starten →